[1] BASKIN HJ J R. The pathogens is and imaging of the tuberous sclerosis complex[J]. Pediatr Radiol,2008, 38(9): 936-952.
[2] CRINO P B, NATHANSON K L. The tuberous sclerosis complex[J]. N Engl J Med, 2006, 355(13): 1345-1356.
[3]NORTHRUP H, KRUEGERr D A. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference[J]. PediatrNeurol, 2013, 49(4):243.
[4] VAN EGHEN A M, NELLIST M. Central TSC2 missense mutations are associated with a reduced risk of infantile spasms[J]. Epilepsy Res, 2013, 103(1):83-87.
[5] JONES A C, DANIELLS C E. Molecular genetics an phenotypic analysis reveals differences between TSC1 andTSC2 associated familial and sporadic tuberous sclerosis[J].Hum Mol Genet, 1997,6(12):2155-2161.
[6] NAPOLIONI V, MOAVER R. Recent advances in neurobiology of tuberous sclerosis complex[J]. Brain, 2009, 31(2):104-111. |
| [1] |
DING Changling, MA Zhenzhen, GAO Fei, CHENG Wenna, ZHANG Junhua, DING Zhaoxing, TIAN Yuejie. The analysis of 236 patients with drug eruption in hospital[J]. 滨州医学院学报, 2019, 42(1): 5-8. |
| [2] |
LI Xinxin, FAN Qizhong, BO Mingxiang, HU Limin, WANG Yu, ZHANG Yanmin. A retrospective study on the clinical efficacy of spironolactone in the treatment of female acne[J]. 滨州医学院学报, 2018, 41(2): 132-134. |
| [3] |
YANG Pengfei, ZHANG Yujie. The influence of Acitretin combinating with NB-UVB and calcipotriol on patients with psoriasis and expression of IL-17,IL-22,IL-23[J]. 滨州医学院学报, 2018, 41(2): 127-131. |
| [4] |
LI Juan, SUN Li, ZHANG Yujie. Clinical analysis of vitiligo treated with 308 nm excimer light[J]. 滨州医学院学报, 2017, 40(2): 94-96. |
|
|
|
|
